FDA Commissioner Margaret Hamburg To Resign in March, Writes Farewell Letter to FDA Colleagues Read more
Biosimilars: FDA Calls For Comment on Data Needed To Show a Product is “Interchangeable”; Estimates Time Burden of Biosimilar Applications to be Same As Traditional Biologic License Applications Read more